<figure><img src="https://assets.bwbx.io/images/users/iqjWHBFdfxIU/iQCwT9SGX55g/v4/-1x-1.jpg"><figcaption><div><p>Source: Bloomberg, 01:13:29</p></div><div></div></figcaption></figure><p>Bloomberg Radio host Barry Ritholtz speaks with Dr. Charles Strom, who has spent the past 30 years in the fast-changing field of genetic testing. The CEO and co-founder of Liquid Diagnostics, which uses new technology to analyze ultra-short DNA fragments in saliva and blood, Strom previously served as medical director for genetic testing at Quest Diagnostics, did groundbreaking work in pre-implantation genetics while at the Reproductive Genetics Institute, and served as a faculty member at the University of Chicago, where he also earned his doctorate and medical degrees.</p>

Bloomberg Radio host Barry Ritholtz speaks with Dr. Charles Strom, who has spent the past 30 years in the fast-changing field of genetic testing. The CEO and co-founder of Liquid Diagnostics, which uses new technology to analyze ultra-short DNA fragments in saliva and blood, Strom previously served as medical director for genetic testing at Quest Diagnostics, did groundbreaking work in pre-implantation genetics while at the Reproductive Genetics Institute, and served as a faculty member at the University of Chicago, where he also earned his doctorate and medical degrees. 

Charles Strom on the Diagnostics Industry

Editorials and commentaries from Bloomberg Opinion